Aiming for Emmetropia

Managing refractive error after multifocal implantation

By DAVID R. HARDTEN, M.D.

Alternatives for Treatment-Resistant Dry Eye

Several formulations are available or are coming soon.

By JOSEPH F. MUSSOLINE, M.D.

Anterior Segment Imaging with the Visante OCT

By ELLA G. FAKTOROVICH, M.D.

At Press Time

Addition acquires AlphaCor implants, and more

Bevacizumab for Preventing CME After Cataract Surgery

One surgeon is using the drug off-label with promising results for patients with retinal disease.

Building an Elective Vision Practice

Overcoming the four barriers to success.

By Kay Coulson

Digital Technology Maximizes Profitability

If you are not there yet, time is running out.

By RICHARD EDLOW, O.D., Towson, MD.

Help Desk

Instrument Insider

Meeting the challenge of safety issues in ophthalmic surgery

By Robert H. Osher, M.D.

Marketplace

Focus on tomometers

New Implantable lens Holds Promise

The Visian ICL greatly expands refractive options.

New M.D.

Finance 101 for new MDs

By Roxanne Woel, M.D.

Physician Training: New Tools Measure Competency

By Andrew Rabinowitz, MD

Rebuilding the Endothelial Layer

Repair may be better than a full corneal transplant.

By RICHARD FICHMAN, M.D.

Refining Patient and Dosage Management

Teaching elderly patients to dose correctly can increase overall satisfaction in cataract surgery.

By WILLIAM C. ASHFORD, M.D.

Rx Perspective

Ranibizumab gives hope to patients with AMD

By Carl D. Regillo, MD, FACS

Spotlight on Technology & Technique

Marco's 3-D Wave: Improved efficiency and precision in refractive care

By LESLIE GOLDBERG, Associate

Stat Tracker

Survey reveals cultural vaiances in vision care knowledge and practice

Structural Analysis: An Important Aspect of Glaucoma Assessment

By LESLIE GOLDBERG, Associate

The Challenge of Compliance

Educating glaucoma patients is the key to success.

By BRIAN FRANCIS, M.D.

Understanding the Eye Codes

Part 2 of this series on choosing the best coding options focuses on the Eye Codes.

By RIVA LEE ASBELL

Viewpoint

From the Chief Medical Editor